Results of the molecular study revealed a complex mechanism of the nanoformulation on ischemia-related neuroinflammation in OHCs, including anti-inflammatory protein A20 stimulation and moderate attenuation of the NFκB signaling pathway. Here, NFKB1 is linked to ischemia.